Search

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.

… Thursday, December 21, 2023 Summary Treatment for high-risk forms of neuroblastoma is effective but can cause serious complications. MSK researchers are investigating using a lower radiation dose to treat this cancer, which occurs in young children. Early results have shown that a reduced radiation dose

Learn about the 21st Century Cures Act, which set out to improve the way providers share information to coordinate the care of their patients and to improve patients’ access to their own medical information.

… Friday, January 31, 2025 Transparency with patients and caregivers is a fundamental part of the mission of Memorial Sloan Kettering Cancer Center (MKS).  We have always believed that you should be empowered with the information you need to understand and manage your care.  The 21st Century Cures Act

MSK’s Chief Health Equity Officer, Carol Brown, MD, participated in a Fireside Chat on Health Equity for the Becker’s Healthcare Virtual Oncology Forum.

… Wednesday, September 8, 2021 MSK’s Chief Health Equity Officer, Carol Brown, MD , participated in a Fireside Chat on Health Equity for the Becker’s Healthcare Virtual Oncology Forum on July 26, 2021.  During the discussion, Dr. Brown spoke in-depth about addressing cancer health disparities that exist

These souped-up versions may help overcome some limitations of existing CAR T cells.

… Thursday, December 30, 2021 Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain types of blood cancers. Now, scientists at Memorial

Brittany Woods, who is completing her doctoral work in the laboratory of physician-scientist Ross Levine, has received a pilot award from the National Cancer Institute that supports outstanding PhD candidates

… Wednesday, October 19, 2016 Brittany Woods , a fifth-year Gerstner Sloan Kettering student, recently received the National Cancer Institute’s Predoctoral to Postdoctoral Fellow Transition Award . This pilot award will support outstanding PhD candidates as they complete their dissertation research and

Doctors and nurses with Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent breast cancer-related lymphedema.

… Thursday, July 27, 2023 Doctors and nurses with  Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent  breast cancer-related lymphedema, an uncomfortable side effect that develops in the months following surgery. Lymphedema

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).

… Monday, December 11, 2023 There is encouraging news about using a blood test to determine which patients with aggressive large B cell  lymphoma were most likely to benefit from having the drug glofitamab (Columvi™) added to their treatment. Results from a phase 2 clinical trial (research study) were

Fighting cancer is often sobering and difficult work, but it is also full of hope. Ask anyone who works at MSK what inspires them, and they will tell you it’s the courage and resilience of the people they care for every day.

… Thursday, September 11, 2025 Dear MSK Community, If you ask the 21,000 people who work at MSK what inspires their tireless commitment to our mission of ending cancer for life, you will hear remarkable responses. Stories about the courage and resilience of the people we care for, an epiphany early in

… Friday, June 6, 2025 From the day Shakima Grant was hired as a care coordinator at MSK, in 2007, she says she knew she had found her purpose. “It always felt like I was meant to be here,” says Shakima, whose grandmother passed away from stage 4 ovarian cancer that very same year. Her grandmother lived

What's it like being LGBTQ in the world of science? We asked some MSK scientists to find out.

… Thursday, June 21, 2018 From left: Jason Lewis, Scott Keeney, Kat Hadjantonakis, Stefanie Windner, and Suleman Hussain. From left: Jason Lewis, Scott Keeney, Kat Hadjantonakis, Stefanie Windner, and Suleman Hussain. Photos by Rick DeWitt. They’re here. They’re queer. They’re scientists. In honor of Pride